How many studies have been conducted on 4 3 Butoxy 4 Methoxybenzyl 2 Imidazolidinone?

BiohacksAI has indexed 63 PubMed studies on 4 3 Butoxy 4 Methoxybenzyl 2 Imidazolidinone. 2% of studies involve human subjects.

What are the main research areas for 4 3 Butoxy 4 Methoxybenzyl 2 Imidazolidinone?

The primary research domains for 4 3 Butoxy 4 Methoxybenzyl 2 Imidazolidinone are 🔬 Oncology, 🔬 Inflammation, 🧬 Hormones. This is based on analysis of 63 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

4 3 Butoxy 4 Methoxybenzyl 2 Imidazolidinone

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone Inhibitor of phosphodiesterases.

63+ PubMed studies analyzed · Evidence Score: 37.5

Research Domains

4 3 Butoxy 4 Methoxybenzyl 2 Imidazolidinone has been studied across 15 research domains including 🔬 Oncology, 🔬 Inflammation, 🧬 Hormones, 🧠 Focus & Attention, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 24% of studies addressing this area.

Loading evidence profile...

This evidence profile for 4 3 Butoxy 4 Methoxybenzyl 2 Imidazolidinone is generated deterministically from 63 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.